Clozapine treatment of schizophrenic patients.

Trial Profile

Clozapine treatment of schizophrenic patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 May 2017

At a glance

  • Drugs Risperidone (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jul 2012 Additional lead trial center identified as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Additional lead investigator identified as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Primary endpoint identified as Brief Psychiatric Rating Scale as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top